A Phase 2a clinical trial testing Tiziana Life Sciences‘ experimental intranasal therapy foralumab in people with nonactive secondary progressive multiple sclerosis (SPMS) has begun dosing its final participant. The INFORM-MS trial (NCT06292923) is evaluating the safety, tolerability, and efficacy of foralumab versus a placebo in up…
Discussion
Measles-mumps-rubella (MMR) and chickenpox (varicella) vaccines do not increase the risk of relapse for people with multiple sclerosis (MS), according to a study involving more than 360 patients. Both vaccines are recommended for people who are not protected, before starting certain MS treatments that suppress the immune system and…
Discussion
Not long ago, I listened to a therapist who works closely with caregiver spouses say something that stopped me cold. Whether the person who is diagnosed means to or not, she explained, the spouse caring for them can sometimes end up in a relationship that has become emotionally abusive. She…
Discussion
Combining high-intensity physical exercise with melatonin supplements may offer greater benefits for people with multiple sclerosis (MS) than either approach alone, a new clinical trial shows. The combination was particularly effective at decreasing markers of cellular stress and inflammation, lowering “bad” cholesterol, and reducing body fat, according to researchers.
Discussion
Common anti-fever medications such as aspirin and acetaminophen may help ease fatigue, improve temperature regulation, and increase exercise capacity in people with multiple sclerosis (MS), according to a systematic review and meta-analysis of studies. Aspirin may be particularly effective at reducing overheating during exercise, while acetaminophen may offer greater…
Get regular updates to your inbox.
